BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) effectively treat various
anxiety disorders, although symptoms of anxiety are often exacerbated during early stages …

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are efficacious in the
treatment of a variety of fear or anxiety disorders. Although they inhibit the reuptake of …

Among drugs that act on serotonergic neurotransmission, selective serotonin (5-HT)
reuptake inhibitors (SSRIs) are now the gold standard for the treatment of anxiety disorders …

BACKGROUND: Like fear conditioning, the acquisition phase of extinction involves new
learning that is mediated by the amygdala. During extinction training, the conditioned …

Selective serotonin reuptake inhibitors (SSRIs) are widely used for the treatment of a
spectrum of anxiety disorders, yet paradoxically they may increase symptoms of anxiety …

Selective serotonin reuptake inhibitors (SSRIs) are reported to exacerbate symptoms of
anxiety when treatment is initiated. These clinical findings have been extended to animal …

Rationale Selective serotonin reuptake inhibitors (SSRIs) are considered first-line
medication for anxiety-like disorders such as panic disorder, generalized anxiety disorder …

Chronic treatment with selective serotonin reuptake inhibitors (SSRIs) alleviates both anxiety
symptoms and associated physiologic disturbances in anxious patients. However, limited …

Selective serotonin reuptake inhibitors are first-line treatment for most anxiety disorders, but
their mechanism of anxiolytic action has not been clarified. Selective serotonin reuptake …

The possible role of 5-HT1A and 5-HT2C receptors in the anxiety induced by fear, acute
treatment with SSRI antidepressants or the 5-HT receptor agonist m-CPP were tested in the …